Pemphigus vulgaris
Exam relevance: in 4 of more than 50 board exam reports · rank 33
- Synonyms
- pemphigus
- Specialty
- Dermatology · Blistering diseases
- Images
- Clinical 3 · Histology 1
- In the app
- 9 flashcards
- Last updated
- 10/2026 · Dr. Pascal Bafteh
Contents
Images (4)

Histology

Definition
Autoantibodies: IgG antibodies against desmogleins, primarily against Desmoglein 3 (Dsg3) (mucosal type) or additionally against Desmoglein 1 (mucocutaneous type).
Immunofluorescence: Intercellular, net-like deposits of IgG and C3 in the epidermis ("fishnet pattern").
Histology: Characteristic is the suprabasal cleft formation due to loss of cell contact (acantholysis). The lowest cell layer remains attached to the basement membrane like a "tombstone pattern".
Clinical features
Clinical Characteristics (Differentiation from Pemphigoid)
Typical age of onset is 30–60 years.
- Blister morphology: The blisters are flaccid/fragile. Due to the thin blister roof, clinically one often primarily sees erosions.
- Location: The disease often begins on the oral mucosa (first symptom in most patients; oral involvement in 50–70%).
- General condition: In contrast to BP, the general condition is often reduced (risk of fluid loss and sepsis).
- Diagnostic signs: Nikolsky-1 is positive, Nikolsky-2 (Asboe-Hansen) is also positive.
- Tzanck test: Acantholytic cells are seen in the blister base smear. /
Diagnosis
Pemphigus Vulgaris Severity Classification (according to PDAI/Clinical)
- Localized form: ≤ 1 cm² mucosa or ≤ 1% skin affected; no significant impairment of quality of life.
- Mild form: PDAI Score ≤ 15.
- Moderate/Severe form: PDAI Score > 15; significant pain and impairment of quality of life.
Differential diagnoses
Pemphigus foliaceus
Stevens-Johnson syndrome
Aphthous ulcers (recurrent aphthous stomatitis)
Bullous pemphigoid
Pemphigus herpetiformis
Pemphigus vegetans (Neumann and Hallopeau types)
Mucous membrane pemphigoid (cicatricial pemphigoid)
Image credits for the thumbnails
- Pemphigus foliaceus: Masryyy, “Pemphigus new photo due to antihypertensive drug”, CC BY-SA 4.0, via Wikimedia Commons · CC BY-SA 4.0 · Source
- Stevens-Johnson syndrome: James Heilman, MD, “Mucosal desquamation in a person with Stevens–Johnson syndrome”, CC BY-SA 3.0, via Wikimedia Commons · CC BY-SA 3.0 · Source
- Aphthous ulcers (recurrent aphthous stomatitis): Dominiqueflores0514, “Canker sore mouth ulcer (cropped)”, CC BY-SA 4.0, via Wikimedia Commons · CC BY-SA 4.0 · Source
- Bullous pemphigoid: Mohammad2018, “Bullous pemphigoid new image”, CC BY-SA 4.0, via Wikimedia Commons · CC BY-SA 4.0 · Source
- Pemphigus herpetiformis: Smith SE, Swanson LA, Wonnaparhown A et al. (JAAD Case Rep 2025), CC BY 4.0, via PubMed Central (PMC12329512) · CC BY 4.0 · Source · cropped
- Pemphigus vegetans (Neumann and Hallopeau types): Marhraoui M, El Moustaoui M, Meziane M et al. (Cureus 2026), CC BY 4.0, via PubMed Central (PMC13616063) · CC BY 4.0 · Source
- Mucous membrane pemphigoid (cicatricial pemphigoid): Oliveira IC, Santos LSD, Rodrigues JDS et al. (Einstein (Sao Paulo) 2026), CC BY 4.0, via PubMed Central (PMC13689956) · CC BY 4.0 · Source
Treatment principles
- Treatment is adapted to severity: in moderate to severe disease, systemic glucocorticoids combined with B-cell-depleting anti-CD20 antibody therapy are first-line.
- In mild disease or where this is contraindicated, glucocorticoids are combined with steroid-sparing immunosuppressants; refractory cases receive intravenous immunoglobulins or immunoadsorption.
- Supportive measures include antiseptic wound care, analgesia for mucosal erosions, sun protection and prophylaxis of steroid-related adverse effects.
Guideline: AWMF guideline register (no. 013-071)
Specific treatment regimens with drugs and doses are covered in the DermaFuchs app.
Keep learning in the app
References (selection)
Cross-references
Mentioned in
- Bullous pemphigoid
- Dermatitis herpetiformis (Duhring disease)
- Epidermolysis bullosa acquisita
- Inherited epidermolysis bullosa
- Epidermolysis bullosa simplex
- IgA pemphigus
- Necrolytic migratory erythema
- Paraneoplastic pemphigus
- Pemphigus foliaceus
- Pemphigus vegetans (Neumann and Hallopeau types)
- Generalized pustular psoriasis (von Zumbusch)
- Stevens-Johnson syndrome (SJS)
Keep learning: test yourself
Two questions from the DermaFuchs app on Pemphigus vulgaris – tap an answer.
Question 1 of 2
Between which ages does Pemphigus Vulgaris typically manifest?
Answer
Correct: ages of 30 and 60. Pemphigus Vulgaris typically manifests between the ages of 30 and 60.
Question 2 of 2
In pemphigus vulgaris, which desmoglein is primarily targeted by autoantibodies in the mucosal type?
Answer
Correct: Desmoglein 3 (Dsg3). Desmoglein 3 (Dsg3) is primarily targeted by autoantibodies in the mucosal type of pemphigus vulgaris.
More questions like these – with explanations and spaced repetition – in the app.
Note: This page is intended for medical education and does not replace diagnosis or treatment decisions in individual cases.